M. Nishimura et al., ROLES OF BRAIN ANGIOTENSIN-II AND C-TYPE NATRIURETIC PEPTIDE IN DEOXYCORTICOSTERONE ACETATE-SALT HYPERTENSION IN RATS, Journal of hypertension, 16(8), 1998, pp. 1175-1185
Objective. To investigate the roles of brain angiotensin II and C-type
natriuretic peptide (CNP) in the hypertensive mechanism of deoxycorti
costerone acetate (DOCA)-salt hypertension. Methods. We injected 50 mu
g/kg CV-11 974, an angiotensin II type-1 receptors antagonist, 30 nmo
l/kg CNP-22, or the vehicle (artificial cerebrospinal fluid) into the
cerebral ventricle or intravenously 5 min before the intracerebroventr
icular infusion of 1.5 mol/l NaCl solution for 30 min into either male
normotensive Wistar rats or DOCA-salt hypertensive rats anesthetized
with urethane, and their arterial pressures and heart rates were conti
nuously recorded. Blood (2 ml) was collected at the end of the infusio
n for the measurement of plasma concentration of arginine vasopressin.
We infused 10 or 50 mu g/kg per day CV-11974, 10 or 50 nmol/kg per da
y CNP-22, or the vehicle (1 mu l/h) into the cerebral ventricles of DO
CA-salt hypertensive rats for 7 days by using osmotic minipumps, and m
easured their systolic arterial pressures, pulse rates, and urinary ex
cretions of vasopressin. Results. Intracerebroventricular pre-administ
rations of CV-11 974 and of CNP-22 inhibited increases in mean arteria
l pressure, heart rate, and plasma vasopressin concentration induced b
y intracerebroventricular infusion of 1.5 mol/l NaCl into normotensive
rats; increases in hemodynamics and plasma level of vasopressin induc
ed by intracerebroventricular infusion of 1.5 mol/l NaCl were suppress
ed by intracerebroventricular pre-injections of CV-11 974, but not of
CNP-22, into DOCA-salt hypertensive rats. Continuous intracerebroventr
icular infusions of 50 mu g/kg per day CV-11974 attenuated hypertensio
n in DOCA-salt treated rats, accompanied by a reduction in urinary exc
retion of vasopressin. Continuous intracerebroventricular infusions of
50 nmol/kg per day CNP-22, however, affected neither hypertension nor
urinary excretion of vasopressin in DOCA-salt hypertensive rats. Conc
lusion. Brain angiotensin II could play a role in the presser mechanis
m of DOCA-salt hypertension by increasing release of vasopressin via t
ype 1 receptors, That brain CNP has an inhibitory effect on release of
vasopressin in acute experiments indicates that the impairment of thi
s inhibitory effect of brain CNP on secretion of vasopressin could be
involved in the pathogenesis of DOCA-salt hypertension in rats. J Hype
rtens 16:1175-1185. (C) 1998 Lippincott-Raven Publishers.